BioSpace News Archive

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development. In this role, Ms. Reiter will drive new business opportunities at Calyxt to support the company’s recently announced go-to-market strategies.

ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced that ALX148 clinical results have been selected for presentation at the SITC 35 th Anniversary Annual Meeting, November 9 –14, 2020. The abstract for our presentation appeared briefly and in error on the SITC website this morning, prior to its intended release on

Updated COVID-19 case projections released by PolicyLab at Children’s Hospital of Philadelphia show parts of the Southeast and Southwest will see infection rates rise significantly over the next four weeks as the early fall wave expands beyond the northern areas of the country to blanket much of the nation.

Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced two upcoming poster presentations describing preclinical evaluations of ATRC-101 at the 35 th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2020), to be held virtually from Nov

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today provided an update on its clinical programs targeting the small molecule correction of alpha-1 antitrypsin deficiency (AATD).

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will present preclinical data from its novel Immunosynthen STING-agonist ADC platform at the 35th Annual Meeting of the Society for Immunotherapy of Cancer

Retrophin, Inc. announced that on October 10, 2020, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 58,750 shares of its common stock to four new employees, consisting of inducement stock options to purchase an aggregate of 37,500 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 21,250 shares of its common stock.

Viemed Healthcare, Inc., a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced that it will host its Quarterly Conference Call on Thursday, November 5, 2020 at 11:00 a.m. EST.

Phelps Hospital has been awarded Magnet Recognition® status, a distinguished designation from the American Nurses Credentialing Center that recognizes commitment to excellence in nursing and dedication to exemplary patient care.